Search

everythinglearnresearchcommunity

for

Search:↓

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Suppressing certain hormones might help prevent prostate cancer.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Large prostates link to more hair loss.

Finasteride treats hair loss but may affect prostate cancer detection.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New drug delivery methods can make natural compounds more effective and stable.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

New drugs for heart disease may be developed from molecules secreted by stem cells.